2-Methyl-N-(oxetan-3-ylidene)propane-2-sulfinamide, 95.0%, 250mg

5,5,8,8-Tetramethyl-2,3,5,6,7,8-hexahydro-1H-cyclopenta[b]naphthalen-1-one, 97.0%, 1g

(R)-1-(6-Methoxypyridin-2-yl)ethanamine, 98%, 1g

3,5-Dibromo-1H-pyrazole-4-carbonitrile, 97%, 100g

1-[(4-NITROPHENYL)METHYL]-PIPERIDINE, 95.0%, 5g

1,3,5-Tris(chloromethyl)-2,4,6-trimethylbenzene, 95.0%, 25g

1,3-Dithiole-2-thione, 97%, 5g

8-methyl-4-(4-methylbenzoyl)-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 2g

n-(2,2-Diethoxyethyl)aniline, 95+%, 1g

N-(Hydroxymethyl)acetamide, 95.0%, 25g

[(2S)-1-methylazetidin-2-yl]methanamine; bis(trifluoroacetic acid), 95.0%, 1g

Colonnes de garde HPLC (analytique) NUCLEODUR® C18 Gravité 5 µm, 4 x 5 mm, 3 pièce(s)

Poudre de néodyme 99,9% 10 g